Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression
Clinical trial NCT03052478 · COMPLETED
Trial details
- NCT number
- NCT03052478
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-10
- Primary completion
- 2019-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.